Acquired angioedema due to C1 inhibitor deficiency research hub

AN OPEN LABEL, SINGLE ARM, EXPLORATIVE TRIAL TO EVALUATE EFFICACY AND SAFETY OF BEROTRALSTAT IN PREVENTING ANGIOEDEMA ATTACKS IN SUBJECTS WITH ACQUIRED ANGIOEDEMA DUE TO C1 INHIBITOR DEFICIENCY (AAE)

This study looks at a daily tablet called Orladeyo for adults with acquired angioedema. This rare condition causes sudden, painful swelling attacks under the skin. Researchers want to find out whether taking this medicine for six months can safely reduce the number and severity of these swelling episodes.